These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8204658)

  • 21. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.
    Kontakou M; Przemioslo RT; Sturgess RP; Limb GA; Ellis HJ; Day P; Ciclitira PJ
    Gut; 1995 Jul; 37(1):52-7. PubMed ID: 7672681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin.
    Ellis HJ; Doyle AP; Sturgess RP; Ciclitira PJ
    Gut; 1992 Nov; 33(11):1504-7. PubMed ID: 1280610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
    Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
    J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative toxicity of different cereals for subjects intolerant of gluten].
    Charbonnier L; Jos J; Mougenot JF; Mossé J
    Reprod Nutr Dev (1980); 1980; 20(4B):1369-77. PubMed ID: 6818635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease.
    Rivabene R; Mancini E; De Vincenzi M
    Biochim Biophys Acta; 1999 Jan; 1453(1):152-60. PubMed ID: 9989255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the putative immunodominant T cell epitopes in coeliac disease.
    Ellis HJ; Pollock EL; Engel W; Fraser JS; Rosen-Bronson S; Wieser H; Ciclitira PJ
    Gut; 2003 Feb; 52(2):212-7. PubMed ID: 12524402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
    Fraser JS; Engel W; Ellis HJ; Moodie SJ; Pollock EL; Wieser H; Ciclitira PJ
    Gut; 2003 Dec; 52(12):1698-702. PubMed ID: 14633945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.
    Fais S; Maiuri L; Pallone F; De Vincenzi M; De Ritis G; Troncone R; Auricchio S
    Gut; 1992 Apr; 33(4):472-5. PubMed ID: 1582589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and enzymatic fragmentation of the coeliac-active gliadin peptide CT-1.
    Wieser H; Belitz HD
    Z Lebensm Unters Forsch; 1992 Jul; 195(1):22-6. PubMed ID: 1502855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa.
    Cornell HJ; Auricchio RS; De Ritis G; De Vincenzi M; Maiuri L; Raia V; Silano V
    Pediatr Res; 1988 Aug; 24(2):233-7. PubMed ID: 3186334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease.
    Barone MV; Gimigliano A; Castoria G; Paolella G; Maurano F; Paparo F; Maglio M; Mineo A; Miele E; Nanayakkara M; Troncone R; Auricchio S
    Gut; 2007 Apr; 56(4):480-8. PubMed ID: 16891357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion.
    Laparra JM; Sanz Y
    J Cell Biochem; 2010 Mar; 109(4):801-7. PubMed ID: 20052669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agglutinating activity of wheat gliadin peptide fractions in coeliac disease.
    De Vincenzi M; Dessi MR; Giovannini C; Maialetti F; Mancini E
    Toxicology; 1995 Jan; 96(1):29-35. PubMed ID: 7863509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo gluten ingestion in coeliac disease.
    Ciclitira PJ; Ellis HJ
    Dig Dis; 1998; 16(6):337-40. PubMed ID: 10207218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence of gliadin fractions to lymphocytes in coeliac disease.
    Verkasalo MA
    Lancet; 1982 Jun; 1(8286):1384-6. PubMed ID: 6123679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity of wheat gliadin fractions in coeliac disease.
    Townley RR; Cornell HJ; Bhathal PS; Mitchell JD
    Lancet; 1973 Jun; 1(7816):1363-4. PubMed ID: 4122746
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunomodulatory activity of recombinant α-gliadin conjugated to cholera toxin in DQ8 transgenic mice.
    Rossi S; Luongo D; Maurano F; Bergamo P; Rossi M
    Immunol Lett; 2017 Jul; 187():47-52. PubMed ID: 28511837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of macrophages by gliadin fragments: isolation and characterization of active peptide.
    Tucková L; Novotná J; Novák P; Flegelová Z; Kveton T; Jelínková L; Zídek Z; Man P; Tlaskalová-Hogenová H
    J Leukoc Biol; 2002 Apr; 71(4):625-31. PubMed ID: 11927649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial in vitro digestion of active gliadin-related peptides in celiac disease.
    Cornell HJ
    J Protein Chem; 1998 Nov; 17(8):739-44. PubMed ID: 9988520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakdown of gliadin peptides by intestinal brush borders from coeliac patients.
    Bruce G; Woodley JF; Swan CH
    Gut; 1984 Sep; 25(9):919-24. PubMed ID: 6381246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.